In this Issue:
Aromatase inhibitors may reduce endometrial cancer risk
Yoga, meditation relieve menopausal symptoms after breast cancer
Platinum-based triple therapy for TNBC and BRCA1/2 mutations
Cisplatin or carboplatin for metastatic TNBC
Lapatinib/capecitabine disappoints in HER2-positive MBC
First-line lapatinib/taxane: poor survival, excess toxicity
Neoadjuvant bevacizumab for HER2-negative disease?
Afatinib + trastuzumab in advanced/metastatic HER2- positive BC
BEEP regimen for brain metastases in WBRT-refractory BC
Oral etoposide effective in heavily pretreated MBC
Please login below to download this issue (PDF)